Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs).

Erica Hlavin Bell; Joseph P McElroy; Jessica Fleming; Cynthia Dawn Timmers; Arup R Chakraborty; Andrea L Salavaggione; Edward G. Shaw; Kenneth D. Aldape; David Brachman; Albert D Murtha; Minhee Won; Minesh P. Mehta; Arnab Chakravarti

Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs).

Erica Hlavin Bell
, Joseph P McElroy
, Jessica Fleming
, Cynthia Dawn Timmers
, Arup R Chakraborty
, Andrea L Salavaggione
, Edward G. Shaw
, Kenneth D. Aldape
, David Brachman
, Albert D Murtha
, Minhee Won
, Minesh P. Mehta
, Arnab Chakravarti

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	34
State	Published - May 20 2016

Disciplines

Biology
Genetics
Pathology
Bioinformatics

Cite this

Bell, E. H., McElroy, J. P., Fleming, J., Timmers, C. D., Chakraborty, A. R., Salavaggione, A. L., Shaw, E. G., Aldape, K. D., Brachman, D., Murtha, A. D., Won, M., Mehta, M. P., & Chakravarti, A. (2016). Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs). Journal of Clinical Oncology, 34.

@article{df4dff0234dc4122b1b0ae259c9001fa,

title = "Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs).",

author = "Bell, \{Erica Hlavin\} and McElroy, \{Joseph P\} and Jessica Fleming and Timmers, \{Cynthia Dawn\} and Chakraborty, \{Arup R\} and Salavaggione, \{Andrea L\} and Shaw, \{Edward G.\} and Aldape, \{Kenneth D.\} and David Brachman and Murtha, \{Albert D\} and Minhee Won and Mehta, \{Minesh P.\} and Arnab Chakravarti",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2016",

month = may,

day = "20",

language = "American English",

volume = "34",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs).

AU - Bell, Erica Hlavin

AU - McElroy, Joseph P

AU - Fleming, Jessica

AU - Timmers, Cynthia Dawn

AU - Chakraborty, Arup R

AU - Salavaggione, Andrea L

AU - Shaw, Edward G.

AU - Aldape, Kenneth D.

AU - Brachman, David

AU - Murtha, Albert D

AU - Won, Minhee

AU - Mehta, Minesh P.

AU - Chakravarti, Arnab

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2016/5/20

Y1 - 2016/5/20

UR - http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2017

M3 - Article

VL - 34

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Comprehensive mutation analysis in NRG Oncology/RTOG 9802: A phase III study of RT vs RT + PCV in high-risk low-grade gliomas (LGGs).

Disciplines

Other files and links

Cite this